Pops Richard F
SEC-identified person · CIK 1126490 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Neurocrine Biosciences INC NBIX | Director | filed 2006 - 2026 |
| Alkermes plc. ALKS | Director · Director and CEO, Alkermes plc | filed 2011 - 2026 |
| Epizyme, Inc. EPZM | Director | filed 2013 - 2020 |
| Acceleron Pharma INC XLRN | Director | filed 2013 - 2019 |
| Alkermes INC ALKS | Director · President and CEO | filed 2006 - 2011 |
| Zalicus Inc. ZLCS | Director | filed 2006 - 2008 |
| Sirtris Pharmaceuticals, Inc. SIRT | Director | filed 2007 - 2007 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.